SAN FRANCISCO--(BUSINESS WIRE)--Fresenius Kabi announced today that Dana-Farber Cancer Institute has received the company’s first Fresenius Kabi Scientific Investigator Award. The winning submission, “Extracorporeal Photopheresis Combined with Low-Dose IL-2 for Chronic Graft versus Host Disease,” was from a team led by John Koreth, M.D., Ph.D., physician-researcher in the Department of Medical Oncology at Dana-Farber Cancer Institute, and William Savage, M.D., Ph.D., physician-researcher in the Department of Pathology at Brigham and Women’s Hospital. Drs. Koreth and Savage will be co-principal investigators on the project.
Help employers find you! Check out all the jobs and post your resume.
